Skip to main content
. 2021 Jul 31;13:17588359211035710. doi: 10.1177/17588359211035710

Figure 1.

Figure 1.

(a) Progression-free survival and (b) overall survival for the first- (1G) and second-generation (2G) EGFR-TKI groups.

TKI, tyrosine kinase inhibitor.